about
Liver Failure due to Acute Viral Hepatitis (A-E)Hepatitis VaccinesEpidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol.Hepatitis B and A vaccination in HIV-infected adults: A reviewArsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003-2012Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based studyEnteric hepatitis viruses.Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.Hepatitis A: Epidemiology and prevention in developing countries.Hepatitis A vaccines.Physicians infrequently adhere to hepatitis vaccination guidelines for chronic liver disease.Genetic relatedness among hepatitis A virus strains associated with food-borne outbreaks.Decreasing risk of hepatitis A infection in León, Nicaragua: evidence from cross-sectional and longitudinal seroepidemiology studies.High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, IranAnti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, MalaysiaDeterminants of anti-hepatitis A antibody seroprevalence in 2- to 19-year-olds in the USA using NHANES 2007-2008A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults.Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in AdultsSelf-reported hepatitis A vaccination as a predictor of hepatitis A virus antibody protection in U.S. adults: National Health and Nutrition Examination Survey 2007-2012Hepatitis A: The Changing Epidemiology of Hepatitis A.Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B.Postinfantile giant cell hepatitis: an etiological and prognostic perspectiveMultilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil.Vectorial entry and release of hepatitis A virus in polarized human hepatocytesShifting epidemiology of hepatitis a infection and vaccination status of children aged 6 months-12 years: time for mass vaccination.Seroepidemiology of hepatitis a infection in northeastern china, Korea, and JapanSeroprevalence of hepatitis a and e viruses based on the third Korea national health and nutrition survey in KoreaPrevention of hepatitis a virus infection, need to vaccinate or not?Herd immunity: recent uses in vaccine assessment.Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.Factors associated with hepatitis A vaccination receipt in one-year-olds in the state of Michigan.Acute hepatitis A in an elderly patient after care worker travel to high endemicity country.Oral fluid and hepatitis A, B and C: a literature review.Hepatitis A virus in the Middle East and North Africa region: a new challenge.Detection and characterization of hepatitis A virus circulating in Egypt.Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine?Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka.A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.Clinical and laboratory features of viral hepatitis A in children.Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation.
P2860
Q26740326-A7B88A74-A51A-48C2-B7C8-40712039E769Q26765433-F4D17B47-98D9-4797-AC4D-C7163F9BDFB5Q26784450-B835F34F-99ED-4114-A445-825F041FD75AQ26799782-2631183D-C1AC-403C-B146-755DC44ADF8DQ28393717-15CA8CE2-212D-4D9B-901B-5A7842D7A8C5Q33289925-4D739AFC-B78F-48D1-91EA-AF015A8B9C5CQ33596383-F1FE1499-999C-4764-A52F-6F59728A31AEQ33716303-28C9AE2F-2B42-4F0C-A814-1C0DA35B5D4CQ34267021-E4E57732-B473-4217-80B5-D1714E9D9C4DQ34787404-39883CE5-EB2B-4066-B7EE-6DA4E9C9B27AQ34907938-FD9E25CB-5228-4C82-8C50-40EE5B0BAA51Q35040081-90B3687E-D1B1-4FE1-AF79-8B7B307AE7FDQ35093540-03A772DE-2B91-449E-9319-F2426F70ACF5Q35230459-7E4BFD66-CA51-42C6-B489-240232EF8A24Q35465620-8D902019-0D57-47FA-B96B-5F2A45198309Q35701038-8162526E-58D5-43D1-B041-31C5AA745642Q35887312-421D9135-86F4-4D06-AD6C-7F1464087A15Q35993848-3046E857-3902-4B20-A742-66CEA76E81D4Q36056997-4210EF59-1D25-4EAB-8DF3-EE0883C7925FQ36269365-08FA33B8-D0AE-422A-8A52-892832B61269Q36707912-5BCB4BE6-682E-4B11-8A07-1984CF10DF45Q36716146-5E15A31A-66E8-45E9-A9BA-1D2861571927Q36790019-3FC5CA2F-37A8-419A-B4A6-60B221D76AE4Q36845875-4E5C6333-17C3-48DB-99D5-57C9958333C5Q36934533-5AA3D6DF-07E2-49F1-92DD-3607E36360CDQ37083095-C4788B2B-4777-4BA1-80A9-3737C9688677Q37155708-9D91B179-57AB-4CB6-B4BE-48DC2C2161E9Q37177113-3F1F12AE-AAC2-4BBF-AE6B-BBF5DD773BD6Q37340454-B3C0C3C1-7A64-4E6D-8FC7-370B7EA96DA5Q37384759-3BA4A1CA-A53C-4222-87AB-34AB6560665BQ37485348-8A65BD85-999E-41BC-820E-D4170A089691Q37694888-D8EC969A-F921-4736-A4FB-A14538291766Q37970474-150A2242-E843-4CEE-B6AB-B7CDF899994DQ38231524-D6F5039C-5B9C-48DE-87DF-AE828E13F059Q39043825-527E81FA-754B-46BC-9B07-3789E719A2E1Q39077628-8D4C2F23-E2D5-4C91-8C86-7F630A5D14B7Q39628691-55FFB75D-AF30-4FCE-B8D9-F221477F7381Q40038985-0C894107-CE44-4C35-AAC0-83AFE4411122Q40259265-AB8F6755-ABE4-42F9-A001-45F8671C175BQ40371822-B62616D2-2FAF-40B1-81CC-CF9E91C98DA8
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hepatitis A in the era of vaccination.
@ast
Hepatitis A in the era of vaccination.
@en
Hepatitis A in the era of vaccination.
@nl
type
label
Hepatitis A in the era of vaccination.
@ast
Hepatitis A in the era of vaccination.
@en
Hepatitis A in the era of vaccination.
@nl
prefLabel
Hepatitis A in the era of vaccination.
@ast
Hepatitis A in the era of vaccination.
@en
Hepatitis A in the era of vaccination.
@nl
P2093
P356
P1476
Hepatitis A in the era of vaccination.
@en
P2093
Annemarie Wasley
Anthony Fiore
Beth P Bell
P304
P356
10.1093/EPIREV/MXJ012
P577
2006-06-14T00:00:00Z